JAK2 and thrombocytosis disease: This indicates that the SF3B1 mutation triggers pancytopenia in the cells and then the JAK2 mutation is acquired as a second-hit mutation, causing thrombocytosis in the patient to rescue the pancytopenia to some extent [56].